Journals / MN Oftalmoloji / 2006 / Cilt: 13 - Sayı: 1

The risk of cardiovascular diseases in patients with amaurosis fugax

Amorozis fugakslı hastalarda kardiyovasküler hastalık riski

Pages
40–43
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

So, it is important to evaluate, follow up and treat these pa­tients in cardiovascular aspects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: It is planned to evaluate the patients with amaurosis fugax complaints for the risk of carrying cardiovascular diseases.
📊
Key Findings & Data:Results: The mean age of the patients was 49.8±14.5 years (range:20-72); 12 of them were females (60%), and 8 of them were males (40%).
💡
Conclusion & Impact:So, it is important to evaluate, follow up and treat these pa­tients in cardiovascular aspects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kalp damar hastalıkları · Ekokardiyografi · Risk faktörleri

Abstract

Purpose: It is planned to evaluate the patients with amaurosis fugax complaints for the risk of carrying cardiovascular diseases. Material and Methods: Twenty patients who have applied to our clinic with this complaint were e­va­luated with transthoracic echocardiography and carotid artery Doppler ultrasonography. Full opht­hal­mologic examinations of the patients have been made; they were asked for accompanying systemic di­seases, and after this, serum lipid profiles have been evaluated. Results: The mean age of the patients was 49.8±14.5 years (range:20-72); 12 of them were females (60%), and 8 of them were males (40%). Ophthalmologic examinations of the patients were normal but 4 of them (20%) had hyperlipidemia, 6 of them (30%) had hypertension, 1 of them (5%) had migraine, 5 of them (25%) had cardiac valvular diseases, and 1 of them (5%) had peripheric vascular diseases in their medical stories. Eleven patients (55%) had lesions detectable by echocardiography; 3 patients (15%) had lesions detectable by carotid Doppler ultrasonography. Discussion: Patients who apply to ophthalmologists with amaurosis fugax complaints have high risk of carrying cardiovascular diseases. So, it is important to evaluate, follow up and treat these pa­tients in cardiovascular aspects.

Özet

Amaç: Amorozis fugaks yakınması olan hastaların kardiyovasküler hastalık taşıma riski açısından de­ğerlendirilmesi planlanmıştır. Gereç ve Yöntem: Kliniğimize bu yakınmayla başvuran 20 hastanın transtorasik ekokardiyografi ve ka­rotis ar­ter Doppler ultrasonografi incelemeleri yapılmıştır. Hastaların tam oftalmolojik muayeneleri ya­pıl­mış, eşlik eden sistemik hastalıklar açısından sorgulamalarını takiben serum lipid profilleri çı­ka­rıl­mış­tır. Bulgular: Yaş ortalaması 49.8±14.5 (sınırlar:20-72) olan hastaların 12’si kadın (%60), 8’i erkek (%40) idi. Oftalmolojik muayeneleri normal olan hastalarımızdan 4’ünde hiperlipidemi (%20), 6’sında hi­pertansiyon (%30), 1’inde migren (%5), 5’inde kalp kapak hastalığı (%25), 1’inde periferik vasküler has­talık (%5) öyküsü mevcuttu. Onbir hastada ekokardiyografik (%55); 3 hastada karotis Doppler ult­ra­sonografik (%15) patoloji saptandı Sonuç: Amorozis fugaks yakınması ile oftalmologlara başvuran hastaların yüksek oranda kar­di­yo­vas­küler hastalıklara sahip olabilme riskleri bulunmaktadır. Bu nedenle, bu hastaların kardiyovasküler yön­den incelenmeleri, takip ve tedavileri önemlidir.

🔖

Cite This Article

YILMAZ, A., LOKMANOĞLU, Ö., ÇİÇEK, D., KARA, E., KARA, A. A., YILDIRIM, Ö. (2006). The risk of cardiovascular diseases in patients with amaurosis fugax. MN Oftalmoloji, Cilt: 13 - Sayı: 1, 40–43. https://ajindex.com/articles/296012

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. The Amaurosis Study Group. Current management of amaurosis fugaks. Stroke 1990
  2. Wilson LA, Warlow CP, Ross Russell RW. Cardiovascular disorders in patients with retinal arterial occlusion. Lancet 1979
  3. Arruga J, Sanders MD. Ophthalmologic findings in 70 patients with evidence of retinal embolism. Ophthalmology 1982
  4. Poole CJM, Ross Russell RW. Mortality and stroke after amaurosis fugax. J Neurol Neurosurg Psychiatry 1985
  5. Fisher CM. Transient monocular blindness associated with hemiplegia. Arch Ophthalmol 1952
  6. Hollenhorst RW. Vascular status of patients who have cholesterol emboli in the retina. Am J Ophthalmol 1966
  7. Bruno A, Russell PW, Jones WL, Austin JK, WeinsteinES, Steel SR. Concomitants of asymptomatic retinal cholesterol emboli. Stroke 1992
  8. Lyons-Wait VA, Anderson SF, Townsend JC, De Land P. Ocular and systemic findings and their correlation with hemodynamically significant carotid artery stenosis: a retrospective study. Optom.Vis Sci 2002
  9. Gautier JC. Amaurosis fugax. N Engl J Med 1993
  10. Ros MA, Magargal LE, Uram M. Branch retinal artery obstruction: a review of 201 eyes. Ann Ophthalmol 1989
  11. Kessler C, Mitusch R, Guo Y, Rosengart A, Sheikhzadeh A. Embolism from the aortic arch in patients with cerebral ischemia. Thromb Res 1996
  12. McCullough HK, Reinert CG, Hynan LS, ve ark. Ocular findings as predictors of carotid artery occlusive disease: Is carotid imaging justified? J Vase Surg 2004
  13. Kirshner RL, Green RM, Searl SS, DeWeese JA. Ocular manifestations of carotid artery atheroma. J Vase Surg 1985
  14. Bull DA, Fante RG, Hunter GC, ve ark. Correlation of ophthalmic findings with carotid artery stenosis. J Cardiovasc Surg (Torino) 1992
  15. Wakefield MC, O'Donnell SD, Goff JM. Re-evaluation of carotid duplex for visual complaints: Who really needs to be studied? Ann Vase Surg 2003
  16. Mouradian M, Wijman CA, Tomasian D, Davidoff R, Koleini B, Babikian VL Echocardiographic findings of patients with retinal ischemia or embolism. J Neuroimaging 2002
  17. O'Sullivan F, Rossor M, Elston JS. Amaurosis fugax in young people. Br J Ophthalmol 1992
  18. Wiznia RA, Pearson WN. Use of transesophageal echocardiography for detection of a likely source of embolization to the central retinal artery. Am J Ophthalmol 1991
  19. Cicik E, Dikici K, Arvas S,